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The APC/C cofactor Cdh1 prevents replicative
stress and p53-dependent cell death in
neural progenitors
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The E3-ubiquitin ligase APC/C-Cdh1 is essential for endoreduplication but its relevance in the
mammalian mitotic cell cycle is still unclear. Here we show that genetic ablation of Cdh1 in
the developing nervous system results in hypoplastic brain and hydrocephalus. These defects
correlate with enhanced levels of Cdh1 substrates and increased entry into the S phase in
neural progenitors. However, cell division is prevented in the absence of Cdh1 due to
hyperactivation of cyclin-dependent kinases, replicative stress, induction of p53, G2 arrest
and apoptotic death of these progenitor cells. Concomitant ablation of p53 rescues apoptosis
but not replicative stress, resulting in the presence of damaged neurons throughout the adult
brain. These data indicate that the inactivation of Cdh1 in vivo results in replicative stress,
cell cycle arrest and cell death, supporting recent therapeutic proposals aimed to inhibit the
APC/C in tumours.
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P
roper progression throughout the cell division cycle
depends on ubiquitin-dependent degradation of cell cycle
regulators at speciﬁc stages. Major E3-ubiquitin ligases that
target proteins for proteasome-dependent degradation during the
cell cycle include the SCF (Skp1/Cullin/F-box) protein complex
and the anaphase-promoting complex/cyclosome (APC/C)1–4.
The APC/C is responsible for targeting critical regulators for
degradation during mitosis and G1 until its activity is inhibited at
the G1/S transition. This multimeric complex requires the
binding of either Cdc20 or Cdh1, two cofactors that recruit the
speciﬁc substrates. Cdc20 is essential for the anaphase onset by
targeting cyclin B and securin for destruction thus promoting the
activation of separase and sister chromatid segregation3. Cdh1, on
the other hand, replaces Cdc20 during mitotic exit and triggers
the ubiquitination of multiple cell cycle regulators (such as aurora
kinases, Tpx2, Plk1, A- and B-type cyclins, and so on), thus
preventing the accumulation of these proteins during the
following G1 phase3,5.
In mammals, genetic ablation of Cdc20 results in metaphase
arrest and embryonic lethality at the two-cell stage6,7. Cdh1 on
the other hand is dispensable for the mitotic cell cycle in yeast,
Caenorhabditis elegans, Drosophila or mammals (ref. 8 and
references herein). During embryonic development, genetic
ablation of Cdh1 results in lethality at mid-gestation owing to
the requirements for Cdh1 during endoreduplication of
trophoblast giant cells8–10. This lethal phenotype has prevented
the detailed analysis of the effects of complete Cdh1 ablation in
postnatal stages although heterozygous mice displayed some
susceptibility to mammary gland tumour development in
agreement with a tumour-suppressor function for this APC/C
cofactor8.
A speciﬁc function of APC/C-Cdh1 in the nervous system was
originally proposed after ﬁnding high levels of Cdh1 and several
core APC/C subunits in postmitotic neurons11. In the last few
years, several studies have shown that the APC/C can regulate
both axonal growth and patterning through Cdh1 (refs 12–14), as
well as presynaptic axonal differentiation and dendrite
morphogenesis by Cdc2015,16. Furthermore, APC/C-Cdh1 may
play a key role in the organization of synapses17,18 and in
homoeostatic plasticity by targeting GluR1 for proteasomal
degradation in neurons19. Cdh1 heterozygous mice display
synaptic and behavioural defects including alterations in
neuromuscular coordination and learning8,9. However, these
mice display a normal architecture of the nervous system
probably owing to the remaining wild-type Cdh1 allele.
The requirements for the APC/C during mitotic exit have been
recently used to propose new therapeutic strategies against
proliferative diseases such as cancer20. Downregulation of APC/
C-Cdc20 results in metaphase arrest and subsequent cell death
suggesting therapeutic uses for the inhibition of mitotic exit in
cancer cells6,21. One possible complication of these strategies
resides in the possible undesired effect of inhibiting APC/C-Cdh1,
as lack of Cdh1 activity may result in the accumulation of
proliferative molecules such as cyclins or oncogenes such as
Pttg1/securin or aurora kinases that could drive increased cellular
proliferation.
Here, we show that elimination of Cdh1 in the developing
nervous system by a Cre recombinase expressed under the nestin
regulatory sequences results in defects in the neural progenitor
compartment, hydrocephalus (accumulation of cerebrospinal
ﬂuid in the cavities of the brain) and death of these mutant
mice. This particular requirement for Cdh1 during neurogenesis
is related to the ability of Cdh1 to prevent replicative stress in
progenitors of the developing brain. In the absence of Cdh1,
Sox2- and Sox9-positive neural progenitors display aberrant
phosphorylation of H2AX, a marker of replicative stress, and
undergo apoptosis. This cell death is prevented after genetic
ablation of p53 suggesting that the ubiquitin ligase APC/C-Cdh1
prevents p53-dependent apoptosis as a consequence of replicative
stress in the developing cortex.
Results
Reduced cortical neurogenesis in Cdh1-null mice. Cdh1 is
highly expressed in the brain11, and we and others previously
observed several defects in behavior, neuromuscular coordination
and learning, together with abnormal proliferation of progenitor
cells in the adult brains of mice with just one functional allele of
the Cdh1-encoding gene, known as Fzr1 in mammals8,9.
However, the role of Cdh1 in the murine nervous system has
not been studied, as homozygous Fzr1 mutation results in
lethality at embryonic day (E)9.5–10.5 owing to an essential role
of Cdh1 in the endoreduplication of trophoblast giant cells in the
placenta8,9. We, therefore used Nestin-Cre transgenic mice22 to
eliminate Cdh1 function in the developing nervous system.
Fzr1(D/D); Nestin-Cre mice were viable but about 50% of them
died during the ﬁrst 2 months of life, whereas Fzr1(lox/lox)
(n¼ 39) or Fzr1(þ /D); Nestin-Cre mice remained viable during
that period (Fig. 1a). Adult Fzr1(D/D); Nestin-Cre mice scored
poorly in the object-recognition assay (Fig. 1b), suggesting defects
in learning that were even stronger than the ones observed in
Fzr1(þ / ) heterozygous mice8. As both Nestin and Cdh1 are
expressed in the mouse retina, we cannot rule out a possible
defect in the object-recognition assay owing to the speciﬁc
ablation of Cdh1 in the eye. Morphological analysis of the skull by
computerized axial tomography scan (Fig. 1c) showed a
progressive increase in the size of Fzr1(D/D); Nestin-Cre heads
at different stages during postnatal development. This defect was
accompanied by the accumulation of liquid in the brain ventricles
as detected by nuclear magnetic resonance imaging (Fig. 1d).
In agreement with the in vivo imaging data, brains of young
(P10–P35) Fzr1(D/D); Nestin-Cre mice displayed enlarged
ventricles, accompanied by thinned cortex and agenesis of the
corpus callosum (Fig. 2a and Supplementary Fig. S1). Closer
inspection of coronal brain sections from P10 Cdh1-deﬁcient
mice in conventional hematoxylin and eosin stainings revealed a
signiﬁcant reduction (26.6±1.6%; mean reduction±s.e.m.; n¼ 3;
Student’s t-test Po0.01) in the thickness of the cortex and the
absence of the corpus callosum (Fig. 2a). The thinning in the
postnatal cortex correlated with a decrease in the thickness of the
cortical plate at E14.5, revealed by antibodies against Tbr1, a
marker for postmitotic neurons, along with an increase in the
area occupied by Tbr2-positive intermediate progenitor cells
(Fig. 2b). Cdh1 is actually highly expressed in embryonic brains
with strong representation in the subventricular area
(Supplementary Fig. S2). Quantitation indeed showed that the
number of Tbr2þ progenitor cells was increased, whereas the
number of Tbr1þ neurons was decreased in mutant cortices
relative to wild types (Fig. 2b), suggesting that Cdh1 is required
for the timely production of cortical neurons. We also scored
reduced numbers of bromodeoxyuridine (BrdU)-retaining cells,
corresponding to postmitotic neurons, in the cortex of P10
Fzr1(D/D); Nes-Cre mice born from females injected with BrdU
at gestational day E15.5, a developmental time point in which
layer II/III cortico-cortical callosal pyramidal neurons are being
generated from cortical progenitors. Cdh1-deﬁcient brains
showed a signiﬁcant reduction in the number of neurons
generated in that assay (Fig. 2c), indicating that neurogenesis
was severely affected when Cdh1 is deleted in Nestinþ cortical
progenitors. Immunoﬂuorescence for Satb2, a postmitotic marker
for upper-layer neurons in the neocortex, and Ctip2, a marker
preferentially expressed in layer V neurons revealed that the
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reduction was even more evident in the deep layers (V–VI) of the
mutant cortex (Fig. 2d).
The robust expression of Cdh1 in postmitotic neurons11 and its
reported function in the control of axon growth and patterning in
the developing mammalian brain12 suggested the possibility that
corpus callosum agenesis and cortical reduced thickness were also
the result of a failure of differentiating neurons to extend their
axons. Interestingly, we examined the cellular density in cortical
layer VI in P10 Cdh1-null mice and found a signiﬁcant increase
(4,268±89 s.e.m. cellsmm 2 in Cdh1-null versus 3,274±78
cellsmm 2 in wild-type brains; n¼ 3; Student’s t-test Po0.01),
which could be because of the defect in establishing normal
projections by Cdh1-deﬁcient neurons. This was consistent with
an evident reduction in the number of cortical axonal projections
in immunohistochemical stainings for myelin basic protein, a
marker of axon myelin sheath (Supplementary Fig. S1). These
data suggest that both reduced neurogenesis and defective axonal
projections may contribute to reduced cortical thickness in the
absence of Cdh1. However, other major forebrain axon tracts
such as the anterior and hippocampal commissures appeared
normal, suggesting that the defect in callosal development did not
result from global defects in axon growth or midline
development.
Generation of a conditional Cdh1 mutant from a Sox2
promoter also resulted in reduced size, problems in motility,
coordination by P10 and increased perinatal death. These defects
were accompanied by a similar cortical phenotype as well as
increased apoptosis in multiple tissues (Supplementary Fig. S3).
All these data together indicated that Cdh1 might be essentially
required for cortical neurogenesis during fetal development.
Lack of Cdh1 results in abnormal DNA replication. To eluci-
date the possible cause of these defects, we analysed cell pro-
liferation during embryonic development in these mutant mice.
By E14.5, many known Cdh1 substrates implicated in mitotic
progression, including aurora A, aurora B, Tpx2 or Cyclin B1
were upregulated in Cdh1-deﬁcient embryos (Fig. 3a,b and
Supplementary Fig. S4). Accordingly, whereas the labelling for
proliferation marker Ki67 was restricted to the ventricular
germinal layer in E14.5 wild-type embryos, it was more extended
in Cdh1-null brains (Fig. 3c). Moreover, E14.5 mutant embryos
displayed an increased incorporation of the nucleotide analogue
BrdU, suggesting increased DNA replication in vivo (Fig. 3d).
We next decided to further analyse the proliferative behavior of
neural progenitors by generating neurospheres in culture. We
ﬁrst tested whether Nestin-Cre was active in these neurospheres
by introducing in these animals a Rosa26-lox-STOP-lox(LSL)-
YFP allele (Fig. 3e). The activity of Cre recombinase on this allele
results in the excision of the LSL cassette, thus driving the
expression of the yellow ﬂuorescent protein (YFP) from the
ubiquitously expressed Rosa26 locus. Cdh1 is normally expressed
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Figure 1 | Cdh1 depletion in the developing nervous system. (a) Survival curve of Fzr1(D/D); Nestin-Cre and control mice. A representative picture of 50
week-old littermates is also shown. (b) Results from the object-recognition assay in mutant (Fzr1(D/D); Nestin-Cre; n¼ 7) and control (Fzr1(þ /D); Nestin-
Cre; n¼9) adult (13–25-week-old) mice. Error bars indicate s.e.m. (c) Analysis of the progression of hydrocephalus in Fzr1(D/D); Nestin-Cre mice at P15,
P25 and P67 by computerized axial tomography scanning. Figures show an overlap of the cranial shape from mutant (red) or control (white) mice in
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in these primary neurospheres and its ablation resulted in the
overexpression of its known substrates such as Tpx2, Cyclin B1,
Geminin or Cdc6 (Fig. 3e) as well as the reduction in cell cycle
inhibitors such as p21Cip1 or p27Kip1, a possible consequence of
the increased levels of the Cdh1-target Skp2, an F-box protein
that targets these cell-cycle inhibitors for degradation
(Supplementary Fig. S4). Genetic elimination of Cdh1 did not
alter the number of primary neurospheres obtained from E14.5
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cortices, but incorporation of the nucleotide analogue EdU in 3–
4-day cultures of primary neurospheres was augmented in Cdh1-
null neurospheres (Fig. 4a) in agreement with the increased
incorporation of BrdU in utero (Fig. 3d). Intriguingly, the size of
these primary neurospheres was signiﬁcantly reduced (20–50% of
the control volume; Fig. 3f) when using E12.5–E17.5 embryos. In
agreement with these observations, the number of secondary
neurospheres generated after disaggregation of the E14.5 primary
neurospheres was markedly reduced (Fig. 3f). These results
suggested that Cdh1 supports normal proliferation of neural
progenitors mostly by regulating their entry into the S phase.
Cdh1 modulates Cdk activity to prevent replicative stress.
Cdh1-deﬁcient ﬁbroblasts are known to display a shorter G1
phase, early entry into the S phase and signs of senescence8,9. We
therefore asked whether the increased entry into the S phase was
causing replicative defects in these neural progenitors.
Phosphorylation of H2AX (gH2AX) is normally present at low
levels and in a dot pattern during normal replication of cells, but
is eliminated as cells exit from the S phase and progress to
mitosis. Lack of Cdh1 resulted in the accumulation of gH2AX
both in primary and secondary neurospheres (Fig. 4a,b).
Importantly, this signal was signiﬁcantly increased in EdU-
negative Cdh1-null cells, suggesting the presence of DNA damage
beyond the S phase. Cdh1-null secondary neurospheres also
presented increased levels of replicative stress, indicated by the
presence of strong pan-nuclear gH2AX signals (in 46% of Cdh1-
null versus 11% control neurospheres; Fig. 4b). The aberrant
gH2AX signal was present in both Sox9-(as analysed in three
different embryos) and Sox2-positive cells of the ventricular layer
(Fig. 4c), whereas this signal was not observed in control embryos
indicating that lack of Cdh1 induced replicative stress in these
neural progenitors in vivo. Importantly, replicative stress was
accompanied by the induction of p53 and apoptosis (Fig. 4d). The
cellular response to replicative stress in the absence of Cdh1
increased in a progressive manner during development (E12.5–
E16.5; Supplementary Fig. S5). Genetic ablation of Cdh1 driven
by the Sox2 promoter similarly resulted in replicative stress,
induction of p53 and apoptosis (Supplementary Fig. S6).
Cdh1 targets for degradation of multiple proteins involved in
many different pathways. However, we reasoned that one of the
major consequences of lack of Cdh1 is the hyperactivation of
Cdks because of the increased levels of cyclins and decreased
levels of Cdk inhibitors (Fig. 3 and Supplementary Fig. S4) during
G1. We therefore explored the effect of partially inhibiting Cdks
in Cdh1-null cells using the small-molecule inhibitor roscovitine.
Partial inhibition of Cdks using a low dose of the inhibitor 3 days
after seeding the cells prevented the replicative stress observed in
Cdh1-deﬁcient cells after disaggregation of secondary neuro-
spheres (Fig. 5a). Importantly, this leads to increased proliferation
(as scored by EdU incorporation; Fig. 5b), suggesting that both
the replicative stress and the defective proliferation is at least
partially induced by increased Cdk activation in the absence of
Cdh1. Similar results were found in cells obtained from primary
neurospheres (Supplementary Fig. S7), although the effect of
roscovitine was not as marked, in agreement with the increased
presence of replicative stress in secondary neurospheres
(Fig. 4a,b). In addition, whereas high concentration of roscovitine
inhibited proliferation (a well-known effect), low dose of this
inhibitor did not induce proliferation in wild-type cells and
actually slightly increased the gH2AX signal (Supplementary Fig.
S7), indicating a speciﬁc protective effect of roscovitine in Cdh1-
null cells. The addition of nucleosides to these cultures also
resulted in a partial protective effect in agreement with recent
observations on the relevance of nucleotide levels to prevent
replicative stress23.
A DNA-damage-like response accompanied by G2 arrest. To
further understand whether the increased entry into the cell cycle
in the presence of replicative defects was accompanied not only
by death but also by defective cell division, we analysed the
pattern of phosphorylation of histone H3 (pH3). This signal
shows a spotted pattern during late G2, whereas mitotic cells are
characterized by fully condensed chromosomes positive for the
pH3 mark24. As observed in Fig. 6a, there was a marked increase
in the percentage of pH3-positive cells with spotted pattern (G2-
like) in the cortex of E14.5 Cdh1-deﬁcient embryos. These cells
frequently displayed duplicated centrosomes (Fig. 6b) and
approximately a twofold increase in nuclear volume (Fig. 6c),
suggesting a DNA content of 4N and conﬁrming that these cells
were arrested after S phase, a phase in which centrosomes are
duplicated.
As Cdh1 has been reported to modulate axonal growth and
patterning12, we also tested the differentiation potential of these
mutant neural progenitors. Cdh1-null neural progenitors
displayed normal ratios of symmetric (leading to two
progenitors or two neurons) versus asymmetric (leading to one
progenitorþ one neuron) cell divisions in vitro (Fig. 7a,b), thus
indicating that Cdh1 is not required for asymmetric division.
Importantly, Cdh1-null cells displayed increased gH2AX signals
in these assays (Fig. 7c). We also isolated and cultured postmitotic
neurons from E14.5 cortices and stained them for b-III-tubulin. A
signiﬁcant number of the neurons generated from Cdh1-null
E14.5 brains displayed abnormal morphology, with poorly
developed neurites and picnotic nuclei (Fig. 7d) in agreement
with cell death induced by Cdh1 loss, as reported previously in
postmitotic neurons25. All together, these data suggest that, in
addition to other possible defects in neurite outgrowth, lack of
Cdh1 results in an abnormal proliferative response in the
developing brain in which neural progenitors display an
accelerated entry into the S phase, replicative stress, arrest in a
G2-like stage and/or cell death in the presence of p53.
A cellular response to Cdh1 deﬁciency in ependymal cells. As
Fzr1(D/D); Nes-Cre mice developed hydrocephalus, we ﬁrst
examined the choroid plexus that showed no gross morphological
aberrancies and absence of signs of replicative stress or damage
(Supplementary Fig. S8). Next, we tested whether the DNA
damage was present in the ependymal layer lining the ventricular
system of the brain. These cells are originated from neural pro-
genitors during late embryonic development26, and defective
integrity of this ependymal layer is known to lead to
hydrocephalus27,28. As shown in Fig. 8, Cdh1-null ependymal
cells displayed defective staining for S100b, a marker of mature
ependymal cells, suggesting abnormal maturation and defective
control of the cerebrospinal ﬂuid in these mutant ventricles.
Importantly, these ependymal cells displayed all the defects
described above, including increased expression of Cdh1
substrates (aurora B and Tpx2; n¼ 3 different embryos) Ki67
and PCNA signals (suggesting unscheduled cell cycle entry and
increased DNA replication), the gH2AX signal (replicative stress),
as well as p53 induction and increased pH3 signal without mitotic
ﬁgures suggesting G2 arrest (Fig. 8a,b). These cell defects were
present both during late embryonic development (E18.5) as well
as in postnatal stages (P10; Fig. 8) in which ependymal cells are
normally quiescent26.
In order to more thoroughly analyse the integrity of the
ependymal layer lining the lateral ventricles, we performed en face
whole-mount staining for the simultaneous detection of S100b,
acetylated-tubulin and g-tubulin to label both cilia and basal
bodies of ependymal cells (Fig. 8c). Whole-mount staining
conﬁrmed a reduced immunoreactivity for S100b protein, and
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decreased density of mature, multiciliated ependymal cells. These
data together indicate a compromised organization of the
ependymal cell layer in Cdh1-null newborns.
p53 is required for apoptosis but not for replicative stress. To
obtain additional insights into the molecular pathways involved
in the DNA damage and apoptotic response in Cdh1-null brain,
we decided to study the effect of Cdh1 depletion in different
genetic backgrounds. We ﬁrst used cyclin B1 mutant mice, as
cyclin B1 is a major Cdh1 substrate and cyclin B1 overexpression
is known to induce apoptotic cell death in terminally
differentiated neurons25. As complete ablation of cyclin B1 leads
to embryonic lethality29, we analysed the survival of Fzr1(D/D);
Nes-Cre; Ccnb1(þ / ) mice harbouring a single copy of the
cyclin B1-encoding gene. As represented in Fig. 9, Fzr1(D/D);
Nes-Cre; Ccnb1(þ / ) mice display early lethality similar to
Fzr1(D/D); Nes-Cre mice with normal copies of cyclin B1,
accompanied by the presence of hydrocephalus in all these
mutant mice. Lack of one allele of cyclin B1 partially stabilized
survival of adult animals although these differences did not reach
statistical signiﬁcance (Fig. 9a).
We next tested the effect of eliminating p53 in a Cdh1-null
background. Deletion of a single allele of p53 had some effect in
the survival of Cdh1-null mice, and Fzr1(D/D); Nes-Cre;
Tp53(þ / ) mice died with slightly accelerated kinetics when
compared with Fzr1(D/D); Nes-Cre; Tp53(þ /þ ) animals
(Fig. 9a). Deletion of both alleles of p53 resulted in a marked
acceleration of lethality within the ﬁrst 10 weeks of age (Fig. 9a).
This lethality was not because of the development of lymphomas
or sarcomas typical of p53-null mice (latency B6 months).
Instead, Fzr1(D/D); Nes-Cre; Tp53( / ) mice died with a more
aggressive phenotype characterized by hydrocephalus and
severely hypoplastic brains (Supplementary Fig. S9). Importantly,
no apoptosis was observed in p53-deﬁcient embryos (Fig. 9b)
suggesting that this protein is essential for cell death caused by
Cdh1 loss. Instead, these double-mutant brains displayed an
increased accumulation of cells positive for the gH2AX signal in
the embryonic cortex (Fig. 9b). These defects were already evident
during embryogenesis (Supplementary Fig. S10) but were more
marked at postnatal stages. The presence of the gH2AX signal
was markedly increased at P10 all over the brain of Fzr1(D/D);
Nes-Cre; Tp53( / ) mice, including not only the ependymal
layer but also cortical regions in which the damaged cells were
rarely observed in Fzr1(D/D); Nes-Cre; Tp53(þ /þ ) animals
(4.1% in Fzr1(D/D); Nes-Cre; Tp53( / ) brains versus 0.4% in
Fzr1(D/D); Nes-Cre; Tp53(þ /þ ) brains; Fig. 10a,b). Damaged
cells included not only Sox2- and Sox9-progenitor cells in the
subventricular zone of these brains but also postmitotic neurons
characterized by the cytoplasmic bIII-tubulin staining (Fig. 10b).
Similarly, lack of p53 did not rescue the accumulation of Ki67
(Supplementary Fig. S11) or G2-like pH3-positive cells
(Supplementary Fig. S12) but rather resulted in an accumulation
of these damaged cells in the brains of Cdh1-null mice. Despite
the presence of these additional damaged cells, lack of p53 did not
rescue the reduced thickness of the cortex of Cdh1-deﬁcient
brains (Supplementary Figs S11, S12). Indeed, double Cdh1; p53
mutant brains presented severe malformations and massive
haemorrhages (Supplementary Fig. S9). All together, these results
suggest that p53 is not involved in the generation of replicative
stress in the absence of Cdh1, but it is critical for preventing
developmental defects caused by the presence of damaged, non-
functional Cdh1-null cells.
Discussion
The APC/C is an essential E3-ubiquitin ligase involved in cell
cycle regulation mostly during mitosis and the following G1
phase3. In addition, this complex is involved in the control of
metabolism and differentiation in various cell types10,30–33, and
recent studies have suggested a crucial role for APC/C-Cdh1 and
APC/C-Cdc20 in postmitotic neurons5,12–16,34.
Whereas APC/C-Cdc20 targets for degradation a few critical
mitotic regulators (A- and B-cyclins, Nek2 and securin), Cdh1 is
more promiscuous and targets for degradation multiple cell cycle
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regulators including Cdc20 targets as well as Cdc20 itself3,5.
Genetic ablation of Cdc20 results in a complete metaphase arrest
in mammals conﬁrming its essential role in the degradation of
cyclin B and securin required for anaphase onset6,7. Cdh1, on the
other hand, is not essential for the cell cycle although lack of
Cdh1 results in early entry into the S phase and reduced
proliferation rate8,9,35. Cdh1 has been proposed to mediate a
DNA damage response to genotoxic stress36 and proliferative
defects caused by Cdh1 deﬁciency are p53 independent35,37. The
irradiation-induced checkpoint is deﬁcient in Cdh1-deﬁcient
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bone marrow cells suggesting a role for Cdh1 in the G2
checkpoint in vivo38.
Genetic deletion of Cdh1 in the mouse embryo results in
placental defects owing to an essential role of this protein in
endoreduplication8,9. Yet, the physiological consequences of
eliminating Cdh1 in mitotic tissues in vivo are unclear. We
have focused on the nervous system, as multiple evidences have
suggested in the past a neural role for Cdh1 (refs 5,11). Cdh1
depletion in neural progenitors resulted in the upregulation of its
known substrates and an initial increase in DNA replication. We
and others have observed in the past that Cdh1-deﬁcient cells
display an early loading of replication complexes resulting in
shorter G1 and premature entry into the S phase8,37. This
phenotype is at least partially because of increased cyclin levels
and reduced amounts of cell cycle inhibitors as a consequence of
Skp2 accumulation (Fig. 3 and Supplementary Fig. S4; see also
refs 8,9). In fact, we have now demonstrated that the replicative
stress and the proliferative defects induced by Cdh1 loss can be
rescued by moderate inhibition of Cdks, suggesting that Cdk
hyperactivation is one of the major mechanisms responsible for
replicative stress in the absence of Cdh1. In the developing cortex,
this is accompanied by the accumulation of p53, a G2-like arrest
and apoptosis. These alterations also affected the ependymal layer
originated from fetal neural progenitors likely resulting in
hydrocephalus, a condition that is known to occur on
compromised integrity of ependymal cells27,28,39. In fact, recent
data suggest that increased death of neural progenitors is
sufﬁcient to induce hydrocephalus in the mouse, and that
defects in these neural progenitors are crucial in the pathogenesis
of neonatal hydrocephalus40. We therefore propose that Cdh1
deﬁciency results in replicative stress in vivo leading to a G2-like
arrest and/or apoptosis of progenitor cells. In the brain, this
results in a reduction in the number of neurons, tissue hypoplasia,
perhaps related to microcephaly as shown for other cell cycle
regulators41, and hydrocephalus.
As suggested from in vitro studies with cultured cells35,37, p53
is not required for the proliferative defects caused by Cdh1
inhibition, and double Fzr1(D/D); Nes-Cre; Tp53( / ) brains
accumulated a signiﬁcant amount of replicative stress.
Consequently, ablation of p53 did not rescue developmental
defects caused by Cdh1 ablation. Intriguingly, p53 deﬁciency
strongly synergized with Cdh1 loss and double-mutant mice died
within the ﬁrst 10 weeks of life with severe brain hypoplasia and
hydrocephalus. This phenotype correlated with lack of apoptosis
in neural progenitors indicating that p53 is essential for the
apoptotic cell death induced by Cdh1 loss (Fig. 9). These results
are in agreement with the reported requirements for p53 in the
apoptotic death of neural progenitors with abnormal cell cycle
progression induced by p57Kip2 or Atr inactivation42,43. In fact,
p53 loss has been shown to exacerbate the effects of DNA
replication defects in several models44–46, further supporting the
idea that the primary defect in Cdh1-deﬁcient cells is related to
abnormal DNA replication. This is likely to be related with the
role of p53 in limiting DNA replication in the presence of
damage. As proposed previously, in the absence of p53, initiation
of DNA replication continues and DNA damage accumulates
leading to a synthetic lethal interaction between replicative stress
and p53 loss44,46. All together, these data suggest a major function
for Cdh1 in protecting neural progenitors against unrestrained
entry into the cell cycle, genomic damage and cell death. Whereas
replicative stress in the absence of Cdh1 is p53 independent, p53
plays a major role in preventing developmental defects by
eliminating these damaged cells from the tissue.
The requirements for the APC/C during the cell cycle have
promoted different studies to evaluate the relevance of this
complex as a cancer target20. The pioneer suggestion that
targeting mitotic exit is a relevant therapeutic strategy21 has
been conﬁrmed using Cdc20-deﬁcient mice6, and the ﬁrst APC/C
inhibitor is currently under preclinical studies47,48. Elimination of
APC/C-Cdc20 activity results in metaphase arrest owing to the
lack of degradation of cyclin B1, and this strategy is more efﬁcient
in killing cells than current microtubule poisons such as
taxanes6,21. These therapeutic approaches are directed against
APC/C-Cdc20 activity, and the concomitant inhibition of Cdh1
has been considered as a putative undesired effect owing to the
proliferative potential of overexpressed Cdh1 substrates (cyclins,
aurora or Plk1 kinases and so on). Contrary to these expectations,
our genetic data suggest that ablation of Cdh1 results in
replicative stress in vivo and a general antiproliferative response
that is not p53-dependent. As Fzr1( /D); Sox2-Cre displayed
defects in the development of multiple organs (Supplementary
Fig. S3), the antiproliferative effect caused by Cdh1 ablation is
likely common to many other tissues. Thus, putative APC/C
inhibitors are unlikely to generate proliferative responses even in
the case of unspeciﬁc inhibition of Cdh1 and with independence
of the p53 status of tumour cells.
Methods
Generation and characterization of mutant mice. All animals were maintained
in a mixed 129/Sv (25%)CD1 (25%)C57BL/6J (50%) background. Mice were
housed in the pathogen-free animal facility of the Centro Nacional de Investiga-
ciones Oncolo´gicas (Madrid, Spain) following the animal care standards of the
institution. These animals were observed on a daily basis and sick mice were killed
humanely in accordance with the Guidelines for Humane End Points for Animals
used in biomedical research. All animal protocols were approved by the ISCIII
committee (Madrid, Spain) for animal care and research. In the mouse, Cdh1 is
encoded by the Fzr1 gene. Fzr1(lox) mice8 were used to conditionally deplete Cdh1
on Cre expression, using Tg.Sox2-Cre mice, that express Cre in embryonic but not
in extra-embryonic tissues49 or Tg.Nestin-Cre mice that express this recombinase
in the developing nervous system (The Jackson Laboratory: strain name: B6.Cg-
Tg(Nes-cre)1Kln/J; stock number: 003771 (ref. 22). Conditional expression of Cre
results in the Fzr1(D) allele, whereas Fzr1( ) refers to the null allele after germline
transmission. These Cdh1-deﬁcient mice were crossed to mice heterozygous for a
null mutation in the Cyclin B1 locus29 or deﬁcient in the tumour suppressor
p5350.The LSL-YFP allele contains a reporter YFP that is only expressed after
recombination of the LoxP sites by the Cre recombinase51.
For histological observation, dissected organs or E12.5–E18.5 embryos were
ﬁxed in 10%-buffered formalin (Sigma) and embedded in parafﬁn wax. Sections of
5 mm thickness were stained with hematoxylin and eosin. Additional immuno-
histochemical examination of the tissues and embryos analysed were performed
using speciﬁc antibodies (Supplementary Table S1).
Animals underwent the object-recognition test following a protocol described
previously52 with minor modiﬁcations8. Brieﬂy, seven Fzr1(D/D); Nestin-Cre and
nine control Fzr1(þ /D); Nestin-Cre adult (13–25-week-old) mice were placed in a
plastic box with opaque walls. The two similar objects (objects X and Y) were plastic
parallelepipeds and the dissimilar object (object Z) was a plastic bottle. Mice were ﬁrst
exposed to the cage and to objects X and Y. After a familiarization period, each mouse
was released in the experimental cage with objects X and Z. The objects and the cage
were wiped with 70% ethanol after each exposure to eliminate odour cues. The total
time of recognition activity was scored manually using a stopwatch and recorded.
Molecular imaging. Computerized axial tomography scanning was performed on
anesthetized mice (1–3% of Isoﬂurane (Isoba Vet)) using the eXplore ista PET-CT
(GE Healthcare) with the following parameters: 200mA, 35 kV, 160m, 16 shots y
360 projections. MMWKS (GE Healthcare) and MicroView software were used to
analyse the images. Nuclear magnetic resonance was performed using a 4.7-tesla
Biospec 47/40 (Bruker). Images of transverse relaxation time T2 were taken.
Isolation and culture of neural progenitors. Mouse cerebral cortices from dif-
ferent embryo stages (E12.5–E17.5) were dissected and gently dissociated manually,
as described previously53. Single dissociated cortical cells were cultured in uncoated
6-well plates for 7 days in a serum-free medium containing Dulbecco’s modiﬁed
Eagle medium with high glucose, sodium pyruvate, glutamine, N2, B27 (all from
Gibco), 2mM N-acetyl-cysteine (Sigma) and 20 ngml 1 each of FGF2
(Invitrogen) and EGF (Gibco) and maintained at 35 C in 6% CO2. For subcloning,
neurospheres were collected and gently dissociated using papain (Worthington) for
30min at 37 C with gentle agitation.
Immunoﬂuorescence and biochemical analysis. EdU (10mM) was added to
neurospheres after 3–4 days of growth in vitro. After 1 h they were attached to
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matrigel-coated coverslips (BD Biosciences), ﬁxed with 4% paraformaldehyde
(Polysciences) for 15–20min at room temperature (RT) and incubated with phos-
phate-buffered saline-Triton 0.5% for permeabilization. Neurospheres were then
incubated with EdU Click-iT cocktail (Invitrogen), blocked with 3% bovine serum
albumin and incubated with primary antibodies (Supplementary Table S1) for 1–2h
at RT. The matching secondary antibodies (Alexa ﬂuor 488, 594 or 647; dilution
1:500) were from Molecular Probes (Invitrogen; Catalogue numbers: A21441,
A11001, A11012, A11005, A21443, A21463). Images were obtained using a laser
scanning confocal microscope TCS-SP5 (AOBS) Leica. For high-throughput micro-
scopy (HTM), neural progenitors were treated for 8 h with Roscovitine or nucleosides
and EdU was added during the last 30min. Then, they were attached to mCLEAR
bottom 96-well plates (Greiner Bio-One) after disaggregation. Images were auto-
matically acquired from each well by an Opera High-Content Screening System
(Perkin Elmer). A  20 magniﬁcation lens was used and pictures were taken at non-
saturating conditions. Images were segmented using the 40,6-diamidino-2-pheny-
lindole (DAPI) staining to generate masks matching cell nuclei from which the
gH2AX mean signal was calculated.
Tissues for immunoﬂuorescence were ﬁxed in 10% buffered formalin (Sigma)
and embedded in parafﬁn wax or frozen in Tissue-Tek OCT compound (Sakura).
Tissue sections were blocked with 3% bovine serum albumin and incubated with
primary antibodies (Supplementary Table S1) for 1–2 h at RT. Secondary
antibodies (Alexa 488, 594 or 647) from Molecular Probes (Invitrogen) were used
and images were obtained using a laser scanning confocal microscope TCS-SP5
(AOBS) Leica. For SEZ whole-mounts, we used protocols established previously54.
Brieﬂy, brains from p10 newborns were extracted and the wall of the lateral
ventricles was dissected and ﬁxed in 4% paraformaldehyde – 0.1% Triton X100.
Incubation with primary antibodies (Supplementary Table S1) was performed for
48 h in 10% calf serum – Triton 0.1% in phosphate-buffered saline blocking buffer
before incubation with appropriate secondary antibodies. Tissue was mounted
using Fluormount-G (Southern Biotech).
For western blotting, neurospheres were harvested after 7–9 days in vitro, lysed
in RIPA buffer and 50 mg of total protein was separated by SDS–PAGE, transferred
to nitrocellulose membranes (Bio-Rad) and probed with different antibodies
(Supplementary Table S1). The secondary antibodies (dilution 1:20000) were HRP-
conjugated antibodies (DAKO; Catalogue numbers: P0447, P0448) and the western
blots were developed using the ECL system (PerkinElmer). Full-blot scans of these
detections are represented in Supplementary Fig. S13.
Statistical analysis. All cellular experiments were repeated at least three times and
analysed statistically. All data from mice are obtained at least from three different
animals. Statistical analysis was performed using Student’s t-, chi-square or log-
rank tests (GraphPad Prism 5). All data are shown as mean±s.d. or mean±s.e.m.
(Fig. 5 and Supplementary Fig. S7); probabilities of Po0.05 were considered
signiﬁcant.
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